OBJECTIVE: To ascertain in obesity the role of body fat distribution (the strongest predictor of morbility and mortality in obese subjects) in determining the degree of endothelial dysfunction, an early marker of atherosclerotic disease. SUBJECTS: 18 premenopausal women with uncomplicated obesity excluding other cardiovascular risk factors and 12 age-matched slim healthy women. MEASUREMENTS: Endothelium-dependent vasodilation, studied as diameter variation in response to an increase in shear-stress, was evaluated in the right common femoral artery of obese and slim subjects by a non invasive approach and compared to glyceril-trinitrate vasodilation. To characterize better the vascular functional andaor structural properties, we studied the arterial wall distensibility by an echo-tracking system. Adipose tissue regional distribution was determined by computerised axial tomography. RESULTS: The endothelium-dependent vasodilation was signi®cantly impaired in obese subjects (P`0.005 versus non-obese subjects) while glyceril-trinitrate vasodilation and arterial distensibility were similar in the two groups. In our obese subjects endothelial-dependent vasodilation was inversely correlated to body fat distribution (visceralasubcutaneous adipose tissue ratio: r À0.624, P 0.0058). In contrast, metabolic parameters (except C-peptide response during oral glucose tolerance test (OGTT): r À0.587, P 0.01), blood pressure values and body weight did not correlate with the endothelial function. CONCLUSION: Uncomplicated obesity per se is characterised by an alteration of the endothelial function; the degree of this vascular damage is predicted by body fat distribution independently of body weight and metabolic and other haemodynamic parameters, and correlates with an index of insulin secretion.
Introduction
The high incidence of atherosclerotic disease in obese subjects has been demonstrated in many studies. 1, 2 An issue that remains open is whether obesity represents a cardiovascular risk factor on its own, as suggested in a 26-y follow-up study in the context of the Framingham heart study, 3 or whether this association is supported by the cluster of metabolic and haemodynamic alterations (dyslipidemia, diabetes, hypertension) that accompany obesity. 4, 5 Moreover, body fat distribution is considered to be the strongest predictor of morbility and mortality in obese subjects, and a relationship between fat distribution and metabolic and cardiovascular complications of obesity has been described. 6 ± 8 In particular, abdominal-visceral fat has emerged as a signi®cant correlation of hyperinsulinemia, increased plasma triglycerides levels, decreased high-density lipoprotein (HDL) levels and elevated blood pressure, all factors that are recognized causes of atherosclerosis. 9 In the presence of the most important atherosclerotic risk factors, such as hypertension, diabetes and dyslipidemia, early signs of the involvement of large conduit arteries include both functional endothelial alterations, affecting the release of vasoactive substances, and altered elasticity of the arterial wall. 10, 11 In particular, endothelial dysfunction has been hypothesised as playing a pivotal role in the pathogenesis of atherosclerosis. 12 A recent study has documented the presence of an endothelial dysfunction in small resistance vessels of obese subjects, 13 but it has not yet been ascertained whether an endothelial dysfunction of a large conduit artery is detectable in uncomplicated obesity and, in particular, whether abdominal fat plays a role in determining the degree of this early sign of vascular involvement.
In order to ascertain to what extent body fat distribution in obesity conditions the degree of the endothelial dysfunction, we selected a group of obese subjects characterised by a low risk for metabolic and cardiovascular complications in relation to sex (female), and hormonal pattern (premenopausal). 14, 15 In addition, we excluded obese women with cardiovascular risk factors other than obesity.
The endothelial function can be studied non-invasively in humans analysing the physiological adaptation of a conduit artery diameter at different blood ow velocities (shear-stress) which has recently proved to be linked to the release of nitric oxide by the endothelial cells. 16 Recent studies have shown an alteration of this shear-stress dependent vasodilation in the presence of hypercholesterolaemia, diabetes mellitus, cigarette smoking and passive smoking. 17 ± 20 Therefore, in the present study the endothelial function of the femoral artery, a typical site for atherosclerotic complications has been investigated in premenopausal obese women who were normoglycemic, normoinsulinemic, glucose normotolerant, normolipemic, normotensive and non-smokers, and then compared with a group of age-matched premenopausal slim women.
In order to exclude alterations in the response to nitric oxide of the smooth muscular cell of the vessel wall, the vasodilation after glyceril trinitrate (GTN) administration was also evaluated. Signs of functional andaor structural stiffness of the vascular wall were researched by measuring with an echo-tracking system the arterial distensibility and compliance in the same arterial site.
To investigate the in¯uence of fat distribution, abdominal visceral and subcutaneous adipose tissue was determined by computerised axial tomography which is the standard reference method. 9 
Methods

Subjects
We studied 30 subjects, 18 obese women (age 32 AE 3 years, mean AE SEM) with body mass index (BMI) higher than 27 kgam 2 and 12 female control subjects (age 35 AE 3 years, NS vs obese) with BMI lower than 25 kgam 2 . We only selected obese women who were normoglycemic (3.33 ± 6.1 mmolal), normoinsulinemic (4 ± 24 mUaml, glucose normotolerant, normolipemic (total cholesterol 3.62 ± 5.17 mmolaL; HDL cholesterolb1.29 mmolaL; low-density lipoprotein (LDL) cholesterol`4.12 mmolal; triglycerides`1.69 mmolal), normotensive and non-smokers. All the women were premenopausal, not following an estroprogestinic therapy and not showing any signs of hirsutism or irregularities of the menstrual cycle. All subjects were studied during the follicular phase of the menstrual cycle. No subject manifested familiar history of cardiovascular diseases. A careful clinical and instrumental examination excluded the presence of any cardiovascular, neurological or renal disease in all subjects.
All subjects gave informed consent and the experimental protocol was approved by our local Ethical Committee.
Anthropometric variables:
The following anthropometric variables were evaluated in all subjects: weight, height and BMI.
Computed tomography measurements
Body fat distribution in obese women was determined by computerised tomography (CT) according to Sjostrom. 21, 22 Total abdominal adipose tissue (AT), visceral abdominal AT, subcutaneous abdominal AT and the visceral to subcutaneous abdominal AT ratio were evaluated by a single scan at the L4 level.
Subject centering was obtained by a longitudinal tomogram at that level. The preselected attenuation interval was À150 to À50 Houns®eld units. 23, 24 A cursor was used to de®ne the total cross-sectional areas and the area of visceral fat (area inside the rectus abdominis muscle). Data were elaborated using a`histogram-based' statistical program.
Metabolic variables
All subjects were studied to exclude dyslipidemia and diabetes. To evaluate the oral glucose tolerance (OGT), patients were given a 75 g glucose load (OGTT). Blood samples for determining glucose, insulin levels and C-peptide levels were taken at 0, 30, 60, 90, 120 and 180 min after glucose administration.
On the day of the haemodynamic study, after overnight fasting, plasma glucose, insulin, total cholesterol, HDL-cholesterol, LDL cholesterol and triglycerides were measured. Plasma glucose was measured using a glucose oxidase method analyser (Beckman Instruments, Palo Alto, CA, USA).
Plasma immunoreactive insulin was measured twice by double-antibody radioimmunoassay using a commercial kit (Diagnostic Products Corporation, Los Angeles, CA, USA) not cross-reacting with proinsulin.
The detection limit of the insulin assay was 1 mUamL and the intra-assay coef®cient of variation was 4.9%. Plasma C-peptide was measured by doubleantibody radioimmunoassay using a commercial kit (Ire, Fleurus, Belgium). The detection limit of the Cpeptide assay was 0.05 pmolamL, and the intra-assay and inter-assay coef®cients of variation were 5.5% and 7.8% respectively.
Serum total cholesterol, triglycerides and HDLcholesterol were measured using a Technicon Autoanalyzer (Technicon Instruments, Bayer Corp, Tarrytown, NY, USA). LDL cholesterol was calculated by using Friedwald formula.
Haemodynamic evaluations
The haemodynamic study was performed at a controlled room temperature of21 C, after a 15 min rest in a supine position. Blood pressure and heart rate were determined automatically, every minute, by an oscillometric recorder (Dynamap, model 845, Critikon, Tampa, Florida, USA) on the left arm. 25 Body fat distribution and endothelium G Arcaro et al
The common femoral artery diameter and¯ow velocity were evaluated at a ®xed distance from its bifurcation using a high resolution ultrasound echoDoppler (HP Sonos 1.000) with a 7.5 MHz linear transducer. The axial resolution of this probe is 0.05 mm, and ultrasonic calipers are accurate to 0.05 mm. The diameter of the femoral artery, considered as the distance between the proximal and the distal wall M-line (the interface between media and adventitia, easier to recognise than the intimal cell layer), was determined from two-dimensional ultrasound images in longitudinal section, at the enddiastolic phase of the cardiac cycle (recognised by means of a simultaneous ECG signal), to avoid possible errors arising from variable arterial distensibility. Mean¯ow velocity was measured by a pulsed Doppler signal at a 60 angle to the vessel. Endotheliumdependent vasodilation was evaluated measuring the modi®cations of the femoral artery diameter sustained by an increase in blood¯ow velocity (shear-stress).
In practice, we measured common femoral artery diameter in basal condition and during accelerated ow velocity (endothelial stimulus) obtained by distal (lower third of leg, and foot) post-ischaemic hyperaemia. Ischaemia was induced by in¯ating a cuff, at a suprasystolic pressure, at the calf level for 8 min.
Haemodynamic measurements during endothelial stimulus were obtained 30 s, 2 min, 4 min and 8 min after cuff de¯ation.
Endothelium-independent vasodilation was evaluated by administering glyceryl trinitrate (GTN: 400 mg sublingual spray) and measuring the femoral artery diameter variation after 3.5 and 5 min.
In our experience, at these time points the more evident response to GTN administration was asserted: in a group of 10 healthy subjects (unpublished data) we evaluated every 30 s the diameter variation of the femoral artery during a 8 min period after GTN administration, and we observed that the most signi®cative increases in diameter were present between 3.5 and 5 min.
For both endothelium-dependent and independent vasodilation diameter variations were expressed as absolute values and percentages of the basal determination.
In addition to the exclusion, by the echo-Doppler system, of anatomical lesions (plaques) on the arterial wall, we used a high-resolution echo-tracking system based on the Doppler shift, to evaluate directly femoral artery wall elasticity. 26 This system allows non-invasive transcutaneous measurements of arterial wall movement throughout the cardiac cycle and hence evaluation of changes in the arterial diameter, as a function of time, in relation to the end diastolic diameter. The following parameters were computed: internal diastolic diameter (Dd), absolute stroke change in diameter (Ds ± Dd) and relative stroke change in diameter [(Ds ± Dd)aDd]. The stiffness of the vascular wall was estimated using a non-invasive approach to the pressure ± diameter curve.
The coef®cient of distensibility (DC) was calculated as DC 2(Ds ± Dd)a(SBP ± DBP)Dd. (SBP is the systolic blood pressure, DBP the diastolic blood pressure.) DC expresses the tangential strain on the arterial wall for a given pulse pressure and relates to the mechanical loading of the artery during a cardiac cycle. Cross-sectional compliance (CC) was derived from the dynamic capacitance dVadP, by rewriting this relation as: CC (Ds ± Dd)ÂDda2(SBP ± DBP). 27 In our laboratory, the intra-observer coef®cient of variation for diameter and¯ow velocity measurement by the echo-Doppler system was in obese subjects 1.8 AE 0.8% and 14AE 3% respectively; in slim subjects 1.6 AE 0.6% and 13AE 3% respectively; the inter-observer coef®cient of variation for diameter and¯ow velocity was in obese subjects 1.9AE 1% and 15 AE 5% respectively; in slim subjects 1.8 AE 0.9% and 15 AE 4% respectively.
For distensibility measurement, the coef®cient of variation was 1 AE 0.6, 6AE 2 and 6 AE 2% for Dd, Ds ± Dd and Ds ± DdaDd, respectively.
Statistical analysis
Descriptive data are expressed as meanAE s.e.m.
Unpaired t-test was used to compare basal mean values in obese subjects with those in slim subjects (the Kruskall-Wallis test was used to compare nonparametrics data). Analysis of variance was performed for the diameter changes by interventions to compare the obese with the control subjects. Simple linear regression analysis was performed to assess the relationship between haemodynamic, metabolic and anthropometric parameters (parameters which did not present normal value distribution had to be transformed into natural logarithms for statistical test purpose). Subsequently these variables were entered into a multiple regression analysis.
Statistical signi®cance was inferred at a P value of`0.05.
Results
Base-line characteristics of the two groups are presented in Table 1 . The BMI mean value of the two groups was signi®cantly different. Age, blood pressure, heart rate, fasting levels of plasma glucose, insulin, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides were similar in the two groups. During OGTT the sum of the plasma glucose values were similar in the two groups, while obese women presented a higher sum of insulin values and C-peptide values.
Basal femoral artery diameter and¯ow-velocity, femoral artery distensibility and compliance were similar in the two groups (Table 2) . No changes in blood pressure and heart rate were observed in either group during the different phases of the study.
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During distal post-ischaemic hyperemia, the increase in femoral artery¯ow-velocity (endothelial stimulus) was signi®cant and comparable in the two groups both in absolute values (obese women 19.4AE 2.2 cmas; slim women25.5 AE 3.2 cmas; NS) and in percentage values (obese subjects128 AE 25%; slim subjects 139 AE 21 %; NS). Nevertheless, in obese women the endothelial-dependent vasodilation (the increase in femoral artery diameter induced by the increase in¯ow-velocity) was signi®cantly reduced both in absolute and percentage values ( Figure 1 ). In particular, the increases in femoral artery diameter at 30 s, 2 min, 4 min and the area under the curve (AUC) of diameter variation as a function of time were signi®cantly blunted in obese women.
In contrast, endothelium-independent femoral artery dilation, evaluated as diameter variation after GTN administration, was similar in the two groups (diameter variation in percentage values: 3.5 min: obese women 11.441.2%, slim women 13.881.4%, NS; 5 min: 10.821.12%, slim women 12.911.31%, NS).
Among the different cardiovascular risk factors (anthropometric, metabolic, haemodynamic) evaluated in our population as a whole, endothelial-dependent vasodilation correlated only with the total sum of insulin (r À0.517, P 0.01) and the total sum of C-peptide (r À0.644, P 0.001) during OGTT. BMI presents a trend of correlation (P 0.06) with endothelial function in the general population (correlation probably justi®ed by the fact that BMI is a parameter for group selection). The correlation between endothelium-dependent vasodilation and the total sum of C-peptide in the total population was con®rmed in a multiple regression analysis including BMI and the total sum of insulin (total sum C-peptide t À3.6, P 0.002; total sum insulin t 0.3, P 0.79; BMI t 0.2, P 0.87).
Therefore we considered in our group of obese women which parameters recognised as cardiovascular risk factors could be related with the degree of endothelial dysfunction. Age, blood pressure, fasting plasma glucose and insulin, sum of glucose and sum of insulin levels during OGTT, total cholesterol, HDL and LDL cholesterol and triglycerides, did not correlate with endothelial vasodilation in our obese women. In this group, a signi®cant inverse correlation was found between endothelial-dependent vasodilation and the total sum of C-peptide levels in response to Body fat distribution and endothelium G Arcaro et al the glucidic load (Table 3) . BMI did not present any correlation with endothelial-dependent vasodilation in obese women. Moreover, we have calculated total body fat volume of obese women based on the total fat area at the L4 ± L5 level according to the Kvist et al 28 formula: the endothelial function did not correlate to total body fat volume in our obese women. Interestingly, a close inverse correlation was observed between endothelial-dependent vasodilation and abdominal fat distribution measured as the visceralasubcutaneous adipose tissue ratio (VISCaSC) ( Table 3 ) (Figure 2) . This last correlation is con®rmed by a multiple regression analysis including the BMI (VISCaSC t À2.3 P 0.03; BMI t 0.7, P 0.52.), suggesting an independent role of fat distribution with respect to body weight. The correlation between endothelialdependent vasodilation and VISCaSC is also con®rmed in a multiple regression analysis including the total sum of insulin (VISCaSC t À2.2, P 0.04; total sum of insulin t À1.7, P 0.12), but not including the total sum of C-peptide (VISCaSC t À1.7, P 0.11; total sum of C-peptide t À1.9, P 0.08).
Discussion
Obesity and associated metabolic and cardiovascular complications are considered to be a major health problem in af¯uent societies. Previous studies have documented that in obese subjects body fat distribution represents an independent predictor of metabolic and hemodynamic alterations leading to cardiovascular morbidity and mortality. 9 The relevance of this study consists in the demonstration that body fat distribution, independently of body weight, predicts the degree of the endothelial dysfunction, an early marker of the atherosclerotic process, in a selected group of non-complicated obese women without hyperglycemia, dyslipidemia and hypertension.
In fact, our study documents in obese subjects a signi®cant reduction of endothelial-dependent vasodilation in a large conduit artery (the femoral artery) which is a typical site for atherosclerotic complications.
This vascular alteration is due to a reduced bioavailability of NO in the vessel wall. In fact: (1) in the presence of an increase in¯ow velocity (endothelial stimulus) similar in the two groups, the vasodilation of the femoral artery resulted signi®cantly reduced in obese women; (2) the responsiveness of the smooth muscle cells of the vessel wall to exogenous NO (GTN administration in a standard dose) was similar in the two groups; and (3) femoral artery distensibility and compliance, markers of structural andaor functional stiffness of the arterial wall, were seen to be similar in the two groups.
Consistent with the data from Steinberg et al 13 of an impaired endothelial function in leg resistance arterioles of obese subjects (evaluated as metacholin-induced¯ow modi®cation during an hyperinsulinaemic euglycemic clamp), in our study population as a whole the endothelial dysfunction only correlated with markers of insulin resistance, even after BMI normalisation. Others metabolic and haemodynamic factors implicated in atherosclerosis and in endothelial dysfunction were similar in the two groups and did not correlate with endothelial function in the population as a whole.
With regard to the determinants of the degree of the endothelial dysfunction in obesity our data show a signi®cant role of body fat distribution. Abdominal fat distribution measured by CT is considered to be a good indicator of metabolic and cardiovascular risk in obesity. 9, 29 It is extremely reproducible and has the greatest predictive values.
In our study the prevalence of visceral fat measured by CT correlates with endothelial dysfunction, an early marker of vascular atherosclerotic damage. In particular, the visceralasubcutaneous adipose tissue area ratio, which is closely related with metabolic and cardiovascular disorders, 8 was the stronger predictor of the degree of the endothelial damage.
In our obese subjects, the correlation between VISCaSC adipose tissue ratio and endothelial function appears to be independent of BMI and of other haemodynamic and metabolic complications (hypertension, hyperglycemia, dyslipidemia) commonly Body fat distribution and endothelium G Arcaro et al associated with insulin resistance. Only an index of insulin secretion during OGTT (total sum of C-peptide) showed a correlation with endothelilum-dependent vasodilation. Therefore, in these uncomplicated obese women we observed the presence of a close association between a marker of endothelial function, body fat distribution measured by CT and a marker of insulin sensitivity. Different mechanisms may support these associations. Recently it has been suggested that high free fatty acid (FFA) levels might be responsible for the relationship between the prevalence of visceral adipose tissue and insulin resistance, hyperinsulinemia and altered lipoprotein metabolism. 9, 30 However, the connection between FFA levels and endothelial function is still debatable. 13, 31, 32 In a recent study Steinberg et al 33 observed the in¯uence of FFA levels on the endothelium-dependent vasodilation. High FFA levels per se could represent a metabolic disturbance that modi®es the endothelial production of vasoactive substances. 9 Recent reports have demonstrated that insulin and IGF-1 stimulate NO release from endothelial cells; insulin resistance at the level of the vascular wall results in alteration in NO metabolism. 34 All these mechanisms might then induce a decrease of endothelial response to vasodilating stimuli.
Alternatively, common genetic, neuroendocrine and environmental antecedents may determine both fat distribution and endothelial dysfunction. 9 Concerning the correlation between the endothelial function damage and an index of pancreatic insulin secretion (sum of C-peptide) in response to the glucidic load (rather than with insulin levels, the latter depending also on the clearance of the hormone), an impairment of insulin-induced NO-dependent vasodilation could represent a signi®cant co-factor contributing to the defect in peripheral glucose utilization (that is an impaired insulin ability to generate an increase in blood¯ow and peripheral glucose disposal) and to the post-glucose challenge of insulin hypersecretion. Former studies have shown that: (1) insulin-induced vasodilation in the normal subject is endothelial NOdependent; 35 (2) endothelial nitric oxide synthesis and insulin sensitivity are positively related in healthy humans; 36 (3) endothelial-dependent vasodilation is impaired in states of insulin resistance; 13 and (4) a reduced insulin-induced vasodilation (that is tissue recruitment) may represent a possible co-factor of insulin resistance through a reduced substrate availability in insulin-sensitive tissue. 37 To support the speci®city of the association between endothelium-dependent vasodilation of a large conduit artery, body fat distribution and a marker of insulin sensitivity, GTN induced vasodilation (endothelial-independent vasodilation) and arterial wall distensibility were not correlated with any cardiovascular risk factor considered.
Moreover to exclude any dependency of our ®nding on the status of the resistance vessels (minimal vascular resistance), we underline that the endothelial stimulus used (that is blood¯ow velocity variation) was similar in the two groups and did not correlate with the vascular response nor with metabolic parameters in obese women. This fact probably highlights that our observation is related to an early phase of vascular involvement in our obese women.
Conclusion
In conclusion, non-complicated obesity in premenopausal women is characterised by an alteration of the endothelial function in a vascular area typically involved in the atherosclerotic process. A strong correlation is evident between body fat distribution, endothelial function and insulin sensitivity, that is independent of body weight and occurs in the absence of hyperglycemia, dyslipidemia and hypertension, conditions usually associated with insulin resistance.
The key to this correlation could be the insulin hypersecretive response, or different metabolic factors (such as FFA levels) related to the prevalence of visceral adipose tissue, or common genetic, neuroendocrine and environmental antecendents, that condition both fat distribution and endothelial dysfunction.
Moreover, the early functional involvement of the vessels in obese subjects could also represent an amplifying co-factor of reduced insulin sensitivity, according to the hypothesis of a reduced capacity for insulin-dependent tissue recruitment.
